Clinical Trials Directory

Trials / Unknown

UnknownNCT02972827

Monitoring Devices in Prediction of Fluid Responsiveness in Severe Sepsis and Septic Shock

Comparison of the Accuracy of Monitoring Devices in Prediction of Fluid Responsiveness in Severe Sepsis and Septic Shock

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
38 (actual)
Sponsor
Santa Barbara Cottage Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Comparison of noninvasive cardiac output monitor (NICOM, Cheetah Medical) with Edwards FloTrac minimally-invasive cardiac output monitor in predicting fluid responsiveness in sepsis and septic shock.

Detailed description

Study will evaluate ability of passive leg raise test to predict fluid responsiveness in patients in septic shock, on vasopressors, using both the NICOM and FloTrac devices. An increase in CI, SVI, or Pulse Pressure of \>10% in response to the passive leg raise will be considered a positive passive leg raise test, and the same indicators will be considered a significant response to a fluid challenge with either crystalloids or colloids.Each device will be evaluated independently, but simultaneously.

Conditions

Interventions

TypeNameDescription
DEVICENICOM/FloTracUse of noninvasive cardiac output and minimally invasive cardiac output monitors
OTHERCrystalloid Fluid Challenge500-1000ml Normal Saline or Plasmalyte intravenous fluid bolus will be given at baseline, and following a positive passive leg raise response as defined by a 10% or greater increase in any of: stroke volume index, cardiac index, or pulse pressure, as measured by the NICOM or FloTrac Monitors.

Timeline

Start date
2015-05-01
Primary completion
2018-06-01
Completion
2022-05-01
First posted
2016-11-23
Last updated
2021-07-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02972827. Inclusion in this directory is not an endorsement.